Related by context. All words. (Click for frequent words.) 73 sd = 71 ± SEM 67 lumbar spine BMD 66 MMSE score 65 ± 64 P = .# 64 MADRS score 64 CI -#.# 63 nonobese 63 interquartile range 62 -#.# ± [002] 62 % CI #.#-#.# [003] 62 WOMAC pain 62 Baseline characteristics 62 p = #.# [002] 62 preoperative PSA 62 univariate analysis 62 hypogonadal 62 p = 62 p = .# [002] 62 clinically meaningful improvement 62 highest tertile 62 mean baseline HbA1c 62 log# copies mL 61 mean ± SEM 61 pCR 61 NIHSS 61 subscale scores 61 % CI #.#-#.# [006] 61 femoral neck BMD 61 posttreatment 61 confidence intervals CIs 61 postintervention 61 n = 61 baseline HbA1c 61 REYATAZ r arm 61 ADAS cog 61 LS BMD 61 EDSS score 61 HAQ DI 61 creatinine ratio 61 HOMA IR 61 univariate analyzes 60 μmol L 60 carotid IMT 60 % Confidence Interval 60 median CD4 60 baseline CD4 60 CR nPR 60 undetectable HBV DNA 60 endometrial thickness 60 ng dL 59 -#.# log# 59 ≥ 59 BPH Symptom Score 59 BMI z 59 % CI #.#-#.# [007] 59 aged ≥ 59 lowest tertile 59 -#.# log# copies mL 59 CORE OM 59 ANOVA 59 biochemical relapse 59 PASI scores 59 serum IGF 59 hip BMD 59 Kaplan Meier analysis 59 #Gy 59 NIHSS score 59 preoperatively 59 IELT 59 6MWD 59 HbA1C levels 59 logMAR 59 mmol l 59 pg ml 59 QTcF 59 Alzheimer Disease Assessment 58 logistic regression model 58 multivariable adjusted 58 nondiabetic patients 58 IPSS 58 mL/min/#.# m 2 58 LVEF 58 nmol liter 58 underwent resection 58 microg 58 β = 58 euthyroid 58 CC genotype 58 Preoperatively 58 kg m² 58 receiving ISENTRESS 58 DAS# CRP 58 DAS# scores 58 QTc 58 GH deficiency 58 NIH CPSI 58 confidence interval CI 58 erythrocyte sedimentation rate 58 Multivariate analyzes 58 T2 lesions 58 HER2 expression 58 virologic response 58 % CI #.#-#.# [005] 58 % CI #.#-#.# [002] 58 mean baseline A1C 58 Cmax 58 μg liter 58 morphometric vertebral fractures 58 MetS 58 metabolite concentrations 58 Univariate analysis 58 intraobserver 57 CNS LS 57 DAS# [002] 57 confidence interval #.#-#.# 57 intact parathyroid hormone 57 tertiles 57 perioperative complications 57 Hb A1C 57 Histologic 57 methotrexate monotherapy 57 pg mL 57 inhibin B 57 fasting insulin 57 logistic regression analysis 57 antibody titer 57 preintervention 57 LV ejection fraction 57 #.#ng/ml 57 lopinavir r arm 57 Expanded Disability Status 57 ipsilateral stroke 57 oxycodone CR 57 overnight polysomnography 57 pulmonary arterial 57 nondepressed 57 Pearson correlation coefficient 57 Index CDAI 57 biopsy Gleason 57 estimated glomerular filtration 57 Secondary efficacy endpoints 57 multiple logistic regression 57 = #.#-#.# 57 comparator arm 57 QRS duration 57 MMSE scores 57 biochemical recurrence 57 enamel defects 57 -#.# ± [001] 57 PCWP 57 oxygen desaturation 57 seronegative 57 bivariate 57 ‰ ¥ 57 HbA 1c levels 57 % CI #.#-#.# [008] 57 definite stent thrombosis 57 mIU L 57 cells uL 57 Health Assessment Questionnaire 57 multivariable analysis 57 ANCOVA 57 log# 57 advanced neoplasia 57 â ‰ ¥ 57 mIU ml 57 umol L 56 MBq 56 IQR 56 serum testosterone 56 odds ratios ORs 56 creatinine levels 56 corrected QT interval 56 OGTT 56 NNT = 56 hemoglobin Hb 56 depressive symptomatology 56 PSA nadir 56 NHANES III 56 #mmHg [001] 56 HRQL 56 tryptophan depletion 56 creatinine clearance 56 ng dl 56 p = #.# [004] 56 ADAS Cog 56 evaluable subjects 56 baseline FEV 56 multivariable Cox 56 PaO 2 56 P ≤ 56 regression coefficient 56 CI #.#-#.# [001] 56 anemia hemoglobin 56 #mg BID [001] 56 baseline A1C 56 subtrochanteric 56 4mg/kg 56 troponin T 56 HIV uninfected 56 Subgroup analysis 56 univariate 56 Kruskal Wallis test 56 apnea hypopnea index 56 μg dL 56 ADCS ADL 56 μg d 56 AUA Symptom Score 56 serum ferritin 56 clinico pathological 56 LAB GHRH 56 baseline Hb 56 HBeAg seroconversion 56 AUC0 56 mmol L 56 antiretroviral naïve 56 EQ 5D 56 fractional anisotropy 56 carotid intima media 56 CCyR 56 Brief Psychiatric 56 kg/m2 56 osteopenic 56 LV dysfunction 56 β blockers 56 timepoint 56 mitral annular 56 neutrophil counts 56 seropositivity 56 Secondary endpoints 56 albumin excretion 56 tipranavir r 56 logistic regression analyzes 56 correlation coefficients 56 adenotonsillectomy 56 aminotransferases 56 #mg QD [002] 56 statistical significance p 56 intima media thickness 56 PSQI 55 tPSA 55 HRQoL 55 methacholine challenge 55 kcal d 55 Primary endpoints 55 -#.# mg dL [002] 55 interobserver 55 CD4 + cell 55 dehydroepiandrosterone sulfate 55 BMI ≥ 55 WOMAC 55 Montgomery Åsberg Depression 55 multivariate analyzes 55 genotypic resistance 55 ml kg 55 thyroglobulin 55 histopathological 55 CI = 55 urine albumin 55 anthropometric measures 55 HIV seronegative 55 covariate 55 histologically proven 55 TIMP 1 55 vitreous haze 55 hypogonadal men 55 progression TTP 55 elevated LDH 55 atazanavir ritonavir 55 prospectively stratified 55 aspartate aminotransferase AST 55 median PFS 55 Insulin sensitivity 55 Rating Scale MADRS 55 tumor histology 55 histologic 55 attain statistical significance 55 Histological 55 Multivariate analysis 55 Crohn Disease Activity 55 leukopenia 55 fasting triglycerides 55 serum ALT 55 underwent CABG 55 #mg/day [001] 55 ug dose 55 intra articular injection 55 preoperative 55 Left Ventricular Ejection Fraction 55 EDSS scores 55 cells mcL 55 carotid stenosis 55 IIEF 55 laterality 55 bortezomib refractory 55 serum estradiol 55 normotensive 55 postoperatively 55 achieved ACR# 55 Hazard Ratio HR 55 diastolic hypertension 55 multivariate Cox 55 serum selenium 55 HbA 1c 55 Scale EDSS 55 mg kg dose 55 allele frequencies 55 fasting plasma 55 HDRS 55 hours postdose 55 Key secondary endpoints 55 virologic failure 55 HGPIN 55 nulliparous 55 mTSS 55 NPH insulin 55 QTc interval 55 tertile 55 QTc intervals 55 elevated troponin 55 antiretroviral naive 55 nondiabetic 55 mmHg p = 55 lispro 55 interrater reliability 55 RLAI 55 recurrent VTE 55 #q# deletion syndrome 55 APACHE II 55 affective psychosis 55 Lumbar spine 55 IBDQ 55 serum concentrations 55 fatty infiltration 55 adiponectin concentrations 55 extracapsular extension 55 transaminase elevations 55 GnRH agonist 55 experienced virologic failure 55 salivary cortisol 55 Bonferroni correction 55 leukocyte count 55 ng mL 55 sUA 55 Exclusion criteria 55 carotid artery intima media 55 μg L 55 baseline FEV1 55 posttransplant 55 #mg/day [002] 55 PREZISTA ritonavir 55 postmenopausal osteoporotic women 55 serum PTH 55 ETDRS 55 HIV RNA 55 glycosylated hemoglobin HbA1c 55 = -#.# 54 PANSS 54 DAS# remission 54 Kaplan Meier 54 pegylated interferon alfa 2b 54 flutamide 54 telomere lengths 54 nonfasting triglyceride levels 54 postop 54 FFNS 54 CI #.#-#.# [002] 54 histological subtype 54 mg ustekinumab 54 Score DAS# 54 statistically significant p = 54 hallux valgus 54 HbA1C 54 mg Pycnogenol 54 mcg BID 54 estimated GFR 54 pT3 54 TEAEs 54 peak VO2 54 abdominal circumference 54 LRTI 54 prospectively defined 54 GH deficient 54 MADRS 54 heterozygotes 54 unpaired t 54 interobserver reliability 54 postprocedure 54 pulmonary artery pressure 54 histologically confirmed 54 glycated hemoglobin HbA1c 54 Psoriasis Area 54 Median survival 54 relapsed MM 54 r = 54 CIN3 54 mU L 54 g dL 54 % CI #.#-#.# [001] 54 spirometric 54 PANSS total 54 MACCE 54 ASCUS 54 BMD measurements 54 sham injections 54 liver histology 54 hemoglobin concentration 54 bladder carcinoma 54 femoral neck 54 secondary efficacy endpoint 54 Median PFS 54 serum urate levels 54 nmol l 54 detrusor 54 specific antigen PSA 54 #.#mmHg 54 lymphocytosis 54 Y BOCS 54 serum leptin 54 fructosamine 54 hemodynamically significant 54 glycated hemoglobin 54 systolic BP 54 nonpregnant women 54 Descriptive statistics 54 locomotor activity 54 mg tid 54 nmol L 54 radical retropubic prostatectomy 54 intravaginal ejaculatory latency 54 logistic regression 54 lactate dehydrogenase LDH 54 arterial oxygen saturation 54 SCr 54 CLA supplementation 54 systolic diastolic 54 nonobese patients 54 χ 54 plasma leptin 54 Unified Parkinson Disease 54 metaplasia 54 familial aggregation 54 Disease Activity 54 male Sprague Dawley 54 TOP2A gene 54 Evaluable 54 anthropometric measurements 54 WOMAC scores 54 HBeAg negative patients 54 dapagliflozin plus 54 premorbid 54 serum creatinine levels 54 BMI waist circumference 54 somatostatin analog 54 rs# [004] 54 de novo AML 54 DLQI 54 IDDM 54 prepubertal 54 tolvaptan 54 HBeAg positive 54 IFN alfa 54 TT genotype 54 alanine aminotransferase 54 Postoperatively 54 Charlson comorbidity index 54 nonsignificant difference 54 oral glucose tolerance 54 Main Outcome Measure 54 #OHD 54 subscales 54 elevated transaminases 54 eosinophil count 54 spine BMD 54 neurodevelopmental outcome 54 waist circumference WC 54 multivariate adjustment 54 pmol L 54 T2DM 54 advanced adenoma 54 serum CRP 54 Kaplan Meier survival 54 infarcts 54 CIBIC plus 54 Scale EDSS score 54 waist circumference measurements 54 lymphocyte count 54 intraclass correlation coefficient 54 HIV HCV coinfected 53 underwent liver transplantation 53 atheroma volume 53 acetabular dysplasia 53 remission CR 53 serum phosphate levels 53 ABC/3TC 53 urinary albumin excretion 53 nonsignificant 53 8mg/kg 53 inotropic 53 gadolinium enhanced 53 UGT#A# * 53 seroconverted 53 dietary calcium intake 53 radiographically 53 microbiologically evaluable 53 urinary excretion 53 histopathologic 53 ventricular myocardium 53 BRCA2 mutation carriers 53 pathologic diagnosis 53 PREZISTA r arm 53 mammographic density 53 hindfoot 53 thyrotropin levels 53 rCBF 53 PCa 53 plasma glucose concentration 53 sperm morphology 53 chi squared 53 IL#B 53 Main Outcome Measures 53 HbA1c levels 53 μg kg 53 Doppler sonography 53 serum albumin 53 Fibromyalgia Impact Questionnaire 53 mITT 53 sustained virological response 53 mg/m2 dose 53 subclinical atherosclerosis 53 endoscopic remission 53 Interrater reliability 53 pairwise comparisons 53 nulliparous women 53 chest radiographs 53 statistically significant differences 53 underwent radical prostatectomy 53 Likert 53 #mg BID [003] 53 NATRECOR ® 53 eGFR 53 microalbuminuria 53 rheumatoid factor 53 urinary albumin 53 hematological relapse 53 NYHA functional class 53 ALT elevation 53 urinary N telopeptide 53 Montgomery Asberg Depression 53 retinal thickness 53 nonfatal MI 53 Scale cognitive subscale 53 serum magnesium 53 timepoints 53 Figure 2C 53 ejection fractions 53 immunostaining 53 baseline serum creatinine 53 antral 53 Subgroup analyzes 53 Viread Emtriva Sustiva 53 comorbidity 53 -#.# mg dL [001] 53 conduction velocity 53 aminotransferase 53 airflow obstruction 53 FEV ^ sub 53 radical prostatectomy RP 53 SBP DBP 53 infliximab monotherapy 53 log# IU mL 53 transaminase levels 53 mineral density 53 HSCT 53 euthymic patients 53 ertapenem 53 nmol L. 53 evaluable 53 Visual Analogue Scale VAS 53 YMRS 53 RYGB 53 hyperintensities 53 SUVmax 53 oxycodone IR 53 foveal thickness 53 HRQOL 53 df = 53 statistically significant 53 clinicopathologic 53 fractional shortening 53 r2 = 53 pT2 53 complete cytogenetic 53 mg BID 53 mL/min/#.# m2 53 dyssynchrony 53 IRLS score 53 hMG 53 Wistar rats 53 uM 53 APTIVUS r 53 ALT flares 53 factorial 53 pretransplant 53 mmol liter 53 ALT elevations 53 syndromal 53 leucopenia 53 systolic dysfunction 53 paresthesias 53 LPV r 53 NMIBC 53 Solid Tumors RECIST 53 MMSE 53 nmol 53 ACR# responses 53 % CI #.#-#.# [004] 53 hepatectomy 53 Ishak fibrosis score 53 multivariate logistic regression 53 nadolol 53 p = .# [001] 53 categorical variables 53 plasma folate 53 elevated creatinine 53 Complication rates 53 hemoglobin A1c levels 53 albumin excretion rate 53 #mg/kg [002] 53 pathologic fractures 53 radical nephrectomy 53 bilateral oophorectomy 53 HBsAg 53 CFQ R 53 serum prostate 53 mEq L 53 mild renal insufficiency 53 moderate renal impairment 53 nonexposed 53 sonographically 53 prostate cancer CaP 53 male Wistar rats 53 tapentadol ER 53 PSADT 53 biventricular repair 53 PASI score 53 Â ± 53 GH secretion 53 nontreated 53 p = #.# [003] 53 PFPS 53 surgically resected 53 normoxic 53 HRCT 53 Operative mortality 53 μg ml 52 postoperative complication 52 nodular partial response 52 undergoing CABG 52 hematopoietic cancers 52 rFSH 52 colorectal adenoma 52 lacunar 52 left ventricular LV 52 randomized multicenter trial 52 mL kg 52 Univariate 52 RLS sufferers 52 MDRD 52 chemoradiation therapy 52 azoospermia 52 graft occlusion 52 dobutamine 52 placebo p = 52 nondemented 52 mcg albinterferon alfa 2b 52 sonographically guided 52 VFQ 52 lactate dehydrogenase 52 extensive metabolizers 52 alexithymia 52 ventricular enlargement 52 #.#mg/dL 52 serum PSA 52 F FDG PET 52 Kaplan Meier curve 52 alanine aminotransferase ALT 52 reach statistical significance 52 affective psychoses 52 CIN2 + 52 hydroxyvitamin D levels 52 ug kg 52 response CCyR 52 EBRT 52 neurocognitive function 52 serum cortisol 52 glycated hemoglobin levels 52 Cronbach alpha 52 AUA BPH Symptom Score 52 limiting generalizability 52 Breslow thickness 52 serum lipid 52 metabolic parameters 52 mITT population 52 p ≤ 52 Tasigna prolongs 52 aminotransferase levels 52 UPDRS motor 52 ß = 52 logistic regression models 52 proton MR spectroscopy 52 Pharmacokinetic parameters 52 bronchoalveolar lavage 52 hepatic resection 52 adjunctive placebo 52 complete cytogenetic response 52 extrapyramidal symptoms 52 TOP2A 52 Poisson regression 52 #OHD levels 52 Free Survival PFS 52 abacavir lamivudine 52 DEXA scan 52 subclinical hyperthyroidism 52 Lucentis monotherapy 52 LDL HDL 52 APOE genotype 52 BENICAR HCT 52 periprocedural 52 ziprasidone 52 TLUS 52 ovariectomized rats 52 z = 52 recurrent venous thromboembolism 52 arterial thickening 52 ipsilateral 52 fasting plasma glucose FPG 52 Fasting plasma glucose 52 ropivacaine 52 nonmetastatic prostate cancer 52 LEXIVA r 52 placebo p 52 Wilcoxon rank sum 52 pelvic lymphadenectomy 52 plain radiographs 52 pretreatment baseline 52 diaphysis 52 nonmetastatic 52 ADCS CGIC 52 immunoreactivity 52 vasopressor 52 dalteparin 52 gadolinium enhancing 52 Hb A1c 52 perimenopausal women 52 autonomic dysfunction 52 BRCA1 mutation carriers 52 aspartate aminotransferase 52 seroconversion 52 T1c 52 Comorbidity 52 neurodevelopmental impairment 52 abnormal cytology 52 autistic traits 52 fasting glucose levels 52 adefovir treated 52 FACIT 52 lymphadenectomy 52 SGRQ 52 bivariate analyzes 52 FDA defined valvulopathy 52 arteriolar 52 submaximal 52 fasting glucose 52 covariance ANCOVA 52 cTnT 52 XIENCE V PROMUS Stent 52 CHD mortality 52 5-FU/LV 52 hyperintensity 52 prespecified 52 lymphopenia 52 BPS IC 52 mRS 52 intraclass correlation coefficients 52 primary aldosteronism 52 Secondary endpoints included 52 CRp 52 efficacy evaluable 52 FOLPI 52 calculated creatinine clearance 52 subscore 52 ADHD RS 52 adrenalectomy 52 actigraphy 52 desvenlafaxine succinate 52 haematologic 52 allele frequency 52 racemic albuterol 52 mg q#h 52 Non inferiority 52 binary logistic regression 52 serum retinol 52 postoperative chemotherapy 52 mCi 52 cytogenetic response 52 doxorubicin cyclophosphamide 52 CVD mortality 52 KRAS mutations 52 T1a 52 binary restenosis 52 #.#-#.# [011] 52 homozygotes 52 hemoglobin A1c HbA1c 52 radiographic progression 52 hip resurfacing arthroplasty 52 FDG-PET/CT 52 triiodothyronine 52 NNRTI resistance 52 DXA scan 52 mg p = 52 ° ± 52 TIMP 52 prospectively randomized 52 androgen suppression 52 statistically significant correlation 52 suicide attempters 52 avosentan 52 mutated K ras 52 fragility fracture 52 per deciliter mg 52 anteroposterior 52 lifetime abstainers 52 echocardiographic 52 mcg QD 52 coronary stenosis 52 glycosylated hemoglobin 52 g dl 52 ACR# response 52 6MWT 52 prostate carcinoma 52 hyper IgE syndrome 52 mL sec 52 virological response 52 hippocampal volumes 52 lupus anticoagulant 52 tipranavir ritonavir 52 serum HBV DNA 52 creatine kinase MB 52 CK MB 52 lymphocyte counts 52 -#.# mmol L 52 mg Lucentis 52 Osteoporotic Fractures 52 ACR Pedi 52 severe exacerbations 52 Pharmacokinetic 52 nonparametric 52 psychosocial variables 52 Leydig cell 52 SNHL 52 hydroxyvitamin D concentrations 52 QoL 52 ROC curves 52 Mania Rating Scale 52 clinicopathological features 52 #.#/#.# mmHg [001] 52 pathologic fracture 52 CSBM 52 statistically nonsignificant 52 artery stenosis 52 coronary calcification 52 Pearson correlation coefficients 52 Kaplan Meier estimate 52 UPDRS 52 proband 52 LUTS 52 nonischemic 51 aortic calcification 51 retest reliability 51 genotypic 51 capillary density 51 radiographic findings 51 Non Responders 51 confirmed CCyR 51 distal radial fractures 51 detectable HCV RNA 51 CDAI score 51 State Examination MMSE 51 hematologic toxicity 51 ECOG PS 51 serum aminotransferase levels 51 interrater 51 serum testosterone levels 51 mmHg diastolic 51 transferrin saturation 51 plasma HCV RNA 51 hsCRP levels 51 Injury Severity Score 51 nonvertebral fractures 51 QRS width 51 concomitant medications 51 deep venous thromboses 51 CHADS2 51 hypophosphatemia 51 URTI 51 IPAH 51 elevated hsCRP 51 achieved statistical significance 51 prepregnancy 51 CSBMs 51 antimuscarinic 51 undetectable viral load 51 systolic blood pressures 51 plus medroxyprogesterone acetate 51 PsA 51 meta regression 51 serum parathyroid hormone 51 severe neutropenia 51 aPTT 51 dyspareunia 51 baseline LDH 51 mg dL 51 ≤ 51 mg qd 51 Symptom severity 51 CrCl 51 Sprague Dawley rats 51 radioiodine therapy 51 p = NS 51 prospective multicentre 51 transrectal ultrasound guided 51 Folfox 51 treated nonoperatively 51 genital arousal 51 IFN α 51 cTnI 51 diastolic BP 51 octreotide LAR 51 μg dl 51 nerve conduction velocity 51 insulin detemir 51 International Prostate Symptom 51 ALND 51 ventricular mass 51 T1 weighted images 51 asymptomatic carotid stenosis 51 vastus lateralis 51 #ng/ml 51 serum lipid levels 51 ultrasonographic 51 ELBW infants 51 seminal vesicle invasion 51 aortic regurgitation 51 Pain Intensity 51 dactylitis 51 noninferiority 51 arterial stiffening 51 RECIST criteria 51 perioperatively 51 ovulatory 51 mg kg Hematide 51 Depressive Symptoms 51 onset diabetes mellitus 51 nephrectomy 51 posttest 51 corticosterone levels 51 noncardiac 51 histopathologic findings 51 comorbidities 51 APOC3 51 laboratory abnormalities 51 interquartile range IQR 51 N telopeptide 51 anal incontinence 51 undergoing coronary angiography 51 #mg dosing group 51 cranial irradiation 51 chest radiography 51 polytherapy 51 RVOT 51 lopinavir r 51 plasma lipids 51 Cardiorespiratory fitness 51 Skin sterol 51 diffusivity 51 androgen deficiency 51 substudy 51 repeat paracentesis 51 adenoma recurrence 51 underwent surgical resection 51 uncorrected visual acuity 51 hepatic enzyme 51 failure MTTF 51 Linear regression 51 VO2 peak 51 DSM IV diagnosis